Pharmaceuticals

Extended-Release Drugs Market Forecast With Insights On Demand And Industry Growth

April 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Extended-Release Drugs Market Expected To Change From 2026 To 2030?

The extended-release drugs market size has witnessed rapid growth in recent years. This market is anticipated to expand from $69.63 billion in 2025 to $77.92 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.9%. Historically, the expansion of this market can be linked to factors such as the increasing prevalence of chronic diseases, a demand for drug formulations centered on patient needs, the limitations associated with immediate-release drugs, a rise in healthcare spending, and advancements in pharmaceutical excipients.

The extended-release drugs market size is projected to experience rapid growth over the next few years. This market is expected to expand to $126.89 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.0%. The anticipated growth during this forecast period can be attributed to the expansion of precision medicine, the increasing adoption of oral controlled-release formulations, the growth of hospital and retail pharmacies, a rising geriatric population, and investments in novel delivery technologies. Prominent trends for the forecast period include personalized dosage regimens, advanced drug delivery systems, patient adherence optimization, novel formulation technologies, and extended-release combination therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12675&type=smp

Which Primary Drivers Are Impacting The Extended-Release Drugs Market Growth?

The anticipated rise in chronic conditions is set to boost the expansion of the extended-release drug market. These conditions are characterized by their duration of a year or more, requiring ongoing medical attention, limiting daily activities, or a combination of these factors. Examples include heart disease, cancer, obesity, and diabetes. Extended-release drug delivery systems are engineered to deliver a consistent level of medication within the body over an extended duration. This design helps sustain a steady therapeutic impact and prevents the variable drug levels often associated with immediate-release drugs. As an illustration, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, reported in January 2023 that projections for 2050 indicate a 99.5% increase in the population aged 50 years and older living with at least one chronic illness, reaching 142.66 million individuals. Consequently, the growing occurrence of chronic conditions is fueling the expansion of the extended-release drug market.

How Is The Extended-Release Drugs Market Categorized Across Its Segment Groups?

The extended-release drugs market covered in this report is segmented –

1) By Type: Sustained Release Drug, Controlled Release Drug

2) By Mode: Over-The-Counter, Prescription

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies, Drug Stores

Subsegments:

1) By Sustained Release Drug: Matrix Systems, Coating Systems

2) By Controlled Release Drug: Osmotic Systems, Microencapsulation Systems, Targeted Delivery Systems

What Trends Are Influencing The Evolution Of The Extended-Release Drugs Market?

Key players in the extended-release drugs market are innovating with products like next-generation extended-release tablets to bolster their product portfolios and secure a competitive advantage. Extended-release tablets represent a pharmaceutical design crafted to gradually release their active components over an extended timeframe. For example, in February 2023, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical firm, gained approval from the U.S. Food and Drug Administration (FDA) for austedo XR (deutetrabenazine). Austedo XR is indicated for treating adults experiencing chorea and tardive dyskinesia associated with Huntington disease. It is offered in 6, 12, and 24 mg dosages. With austedo XR’s approval, individuals with tardive dyskinesia and Huntington disease chorea now have an additional effective treatment choice. This allows patients to manage these conditions with a medication administered once daily. The creation of austedo XR, which presents a practical and efficient therapeutic alternative for those with specific movement disorders, indicates a notable progression in the care of these illnesses.

Which Firms Are Influencing Competition In The Extended-Release Drugs Market?

Major companies operating in the extended-release drugs market are Pfizer Inc., AbbVie Inc., Novartis AG, Sanofi SA, GlaxoSmithKline PLC, AstraZeneca Plc, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Purdue Pharma LP, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Mallinckrodt LLC, Allergan plc, Janssen Pharmaceuticals Inc., Noven Pharmaceuticals Inc., Mayne Pharma Group Ltd., Neos Therapeutics Inc., Oakwood Laboratories LLC, Roxane Laboratories Inc., Watson Pharmaceuticals Inc.

Get The Full Extended-Release Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/extended-release-drugs-global-market-report

Where Is The Extended-Release Drugs Market Most Concentrated Geographically?

North America was the largest region in the extended-release drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the extended-release drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Extended-Release Drugs Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/extended-release-drugs-global-market-report

Browse Through More Reports Similar to the Global Extended-Release Drugs Market 2026, By The Business Research Company

Extended Release Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/extended-release-drugs-global-market-report

Controlled Release Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795